Table 3. Zinc status in patients with hair loss and control subjects.

AA: alopecia aerate; FPHL: female pattern hair loss; MPHL: male pattern hair loss; TE: telogen effluvium

Zinc (µg/dl)	AA (n=28), n (%)	MPHL (n=16), n (%)	FPHL (n=22), n (%)	TE (n=59), n (%)	Hair Loss Group total (n=125), n(%)	Control Group total (n=75), n (%)
<50	4 (14.3)	0 (0.0)	0 (0)	7 (11.8)	11 ( 8.8)	0 (0)
50-70	11 (39.3)	8 (50.0)	9 (40.9)	26 (44.1)	54 (43.2)	1 (1.33)
>70	13 (46.4)	8 (50.0)	13 (59.1)	26 (44.1)	60 (48.0)	74 (98.66)